Adverse Events of Radioligand Therapy in Patients with Progressive Neuroendocrine Neoplasms: The Biggest Eastern European Prospective Study.

Databases from developed countries like Japan, Switzerland, Italy, or Norway have also been recently bringing data showing an increasing trend in the incidence of NENs [ 12 , 13 ].

also in 63,971 other papers